Based on the Innovative Pharmaceutical Biotech Ltd stock forecast from 0 analysts, the average analyst target price for Innovative Pharmaceutical Biotech Ltd is not available over the next 12 months. Innovative Pharmaceutical Biotech Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Innovative Pharmaceutical Biotech Ltd is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Innovative Pharmaceutical Biotech Ltd’s stock price was HKD 0.2. Innovative Pharmaceutical Biotech Ltd’s stock price has changed by +0.00% over the past week, -1.48% over the past month and -1.48% over the last year.
No recent analyst target price found for Innovative Pharmaceutical Biotech Ltd
No recent average analyst rating found for Innovative Pharmaceutical Biotech Ltd
Company Overview Innovative Pharmaceutical Biotech Ltd
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; healthcare management; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong. Address: West Tower Shun Tak Centre, Sheung Wan, Hong Kong Read Less
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is...Read More
Frequently Asked Questions About Innovative Pharmaceutical Biotech Ltd (0399:HK) Stock
Stock Target Advisor's fundamental analysis for Innovative Pharmaceutical Biotech Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on 0399:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0399:HK's stock to indicate what its average analyst target is.
0399:HK stock's Price/Earning ratio is 21.66.
Our analysis grades 0399:HK stock's Price / Earning ratio at F. This means that 0399:HK stock's Price/Earning ratio is above 54% of the stocks in the Household & Personal Products sector in the HK exchange.
Based on this 0399:HK may be a overvalued for its sector.
The last closing price of 0399:HK's stock was HKD 0.20.
The most recent market capitalization for 0399:HK is HKD 0.34B.
Unfortunately we do not have enough analyst data on 0399:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Innovative Pharmaceutical Biotech Ltd's stock.
As per our most recent records Innovative Pharmaceutical Biotech Ltd has 20 Employees.
Innovative Pharmaceutical Biotech Ltd's registered address is West Tower Shun Tak Centre, Sheung Wan, Hong Kong.
You can get more information about it from Innovative Pharmaceutical Biotech Ltd's website at https://www.ipb.asia.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0399:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
